Clinical Trial

Oxybutynin for Post-surgical Bladder Pain and Urgency

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2019-05-13; most recent amendment 2026-01-28.
Trial Details
NCT Number NCT03952299
Lead Sponsor University of California, Davis
Conditions Overactive Bladder Syndrome, Neuropathic Bladder
Enrollment 100 participants
Start Date 2021-09-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-29